In a power move set to rattle the European healthcare landscape, KKR & Co. has inked a deal to acquire Sweden’s Karo Healthcare from EQT in a blockbuster transaction reportedly valued between €2.5 ...

KKR (NYSE:KKR) agreed to acquire Karo Healthcare from a fund managed by private equity firm EQT, with the aim to accelerate the European healthcare platform's growth, the companies said on Wednesday.

Under EQT's ownership, Karo has transformed from a Nordic specialty pharma business into a pan-European consumer healthcare platform, driven by strong organic growth, eight strategic acquisitions ...

KKR & Co. agreed to acquire Swedish consumer-health company Karo Healthcare from EQT AB, defying the downbeat sentiment around dealmaking globally after US President Donald Trump unveiled his ...

Private equity giant KKR is reportedly close to buying E45 maker Karo Healthcare in a deal worth over €2.5bn. KKR beat out bids from other rival private equity firms after Karo’s owner EQT began ...

KKR is nearing a deal to buy E45 maker Karo Healthcare in a buyout that values the healthcare company at about 2.6 billion euros ($2.85 billion), Financial Times reports, citing unnamed sources.

KKR has secured a €2.6bn deal to buy Karo Healthcare, the maker of E45 moisturiser, defying a wider slump in dealmaking during the fallout from US President Donald Trump’s tariff policy.

STOCKHOLM--Swedish buyout group EQT has agreed to sell consumer-healthcare company Karo Healthcare to KKR. EQT first invested in the company in 2019 before taking it private in 2022 in a deal that ...

Maple syrup, often called Canada’s “liquid gold,” has long been a target for fraudulent activities, such as the dilution or substitution with other syrups, due to its high demand.